DOSAGE REGIMENS FOR HCV COMBINATION THERAPY COMPRISING BI201335, INTERFERON ALPHA AND RIBAVIRIN

• 收藏
• 分享

专利权人:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

发明人:

HAEFNER, CARLA,STEINMANN, GERHARD,STERN, JERRY O

申请号：

NZ59846510

公开号：

NZ598465A

申请日:

2010.10.27

申请国别(地区):

NZ

年份:

2013

代理人:

摘要：

Patent No. 598465 Disclosed is the use of a therapeutic combination comprising: (a) Compound (1) or a pharmaceutically acceptable salt thereof: (b) an interferon alpha and (c) ribavirin, in the preparation of a medicament for treating hepatitis C viral (HCV) infection or alleviating one more symptoms thereof in a patient, wherein the first dose of Compound (1), or a pharmaceutically acceptable salt thereof, is formulated for administration to the patient double in quantity by weight to the subsequent doses thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/